World Journal of Dentistry

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  15 (2024)
Volume  14 (2023)
Volume  13 (2022)
Volume  12 (2021)
Volume  11 (2020)
Volume  10 (2019)
Volume  9 (2018)
Volume  8 (2017)
Volume  7 (2016)
Volume  6 (2015)
Volume  5 (2014)
Volume  4 (2013)
Volume  3 (2012)
Volume  2 (2011)
Volume  1 (2010)
Related articles

VOLUME 14 , ISSUE 5 ( May, 2023 ) > List of Articles

CASE REPORT

Co-existence of Odontogenic Myxoma and Fragile X Syndrome: A Rare Report and Review of Management Considerations

Rajanikanth B Rajaram, Mirunalini Gunasekaran, Dominic Augustine, Kavitha Prasad

Keywords : Case report, Fragile X syndrome, morbidity, odontogenic myxoma, pediatric patients, peripheral ostectomy

Citation Information : Rajaram RB, Gunasekaran M, Augustine D, Prasad K. Co-existence of Odontogenic Myxoma and Fragile X Syndrome: A Rare Report and Review of Management Considerations. World J Dent 2023; 14 (5):466-470.

DOI: 10.5005/jp-journals-10015-2242

License: CC BY-NC 4.0

Published Online: 02-08-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Background and aim: The aim of this article is to report a rare case of odontogenic myxoma (OM) with concurrent fragile X syndrome (FXS). OM has a high rate of recurrence, which makes its management very significant. Case description: A 10-year-old male patient reported to the dental outpatient department (OPD) with a chief complaint of swelling on his right lower side of the face for 3 months. His medical history revealed “FXS” and epilepsy. The swelling was evident extra-orally, and on intraoral examination, it extended into the buccal vestibule on the right side from 44 to 47 regions. Radiographic examination revealed a well-defined radiolucency measuring 2 × 2 cm. On histopathological examination, a final diagnosis of OM was established. Excision of the lesion was performed under general anesthesia, and no recurrence has been noted yet. Conclusion: This is the first report in the literature on OM occurring in an FXS patient treated with enucleation and peripheral ostectomy. The existence of OM, FXS, and epilepsy is a challenging aspect to manage. Clinical significance: Oral surgical procedures in patients with FXS can be performed with a good prognosis. The presence of comorbidities and locoregional challenges should be addressed for optimum management outcomes.

HTML PDF Share
  1. Ansari A, Thomas A, Bohra RB, et al. Recurrent myxoma of the maxilla: a rare case. Otolaryngol Case Rep 2019;10:1–4. DOI: 10.1016/j.xocr.2018.12.002
  2. Gupta S, Grover N, Kadam A, et al. Odontogenic myxoma. Natl J Maxillofac Surg 2013;4(1):81–83. DOI: 10.4103/0975-5950.117879
  3. Zimmerman DC, Dahlin DC. Myxomatous tumors of the jaws. Oral Surg Oral Med Oral Pathol 1958;11(10):1069–1080. DOI: 10.1016/0030-4220(58)90289-5
  4. Shivashankara C, Nidoni M, Patil S, et al. Odontogenic myxoma: a review with report of an uncommon case with recurrence in the mandible of a teenage male. Saudi Dent J 2017;29(3):93–101. DOI: 10.1016/j.sdentj.2017.02.003
  5. Chaudhary R, Agarwal V, Kaushik AS, et al. Involvement of myocyte enhancer factor 2c in the pathogenesis of autism spectrum disorder. Heliyon 2021;7(4):e06854. DOI: 10.1016/j.heliyon.2021.e06854
  6. Ciaccio C, Fontana L, Milani D, et al. Fragile X syndrome: a review of clinical and molecular diagnoses. Italian J Pediatr 2017;43(1):39. DOI: 10.1186/s13052-017-0355-y
  7. Salcedo-Arellano MJ, Dufour B, McLennan Y, et al. Fragile X syndrome and associated disorders: Clinical aspects and pathology. Neurobiol Dis 2020;136:104740. DOI: 10.1016/j.nbd.2020.104740
  8. Heulens I, Suttie M, Postnov A, et al. Craniofacial characteristics of fragile X syndrome in mouse and man. Eur J Hum Genet 2013;21(8):816–823. DOI: 10.1038/ejhg.2012.265
  9. Friedrich RE, Kohlrusch FK, Luebke AM. Symptomatic mandibular fibrous dysplasia with concurrent triple X-and premutation stage fragile-X-syndrome: case report with short literature survey. Anticancer Res 2019;39(12):6769–6780. DOI: 10.21873/anticanres.13892
  10. Sabbagh-Haddad A, Haddad DS, Michel-Crosato E, et al. Fragile X syndrome: panoramic radiographic evaluation of dental anomalies, dental mineralization stage, and mandibular angle. J Appl Oral Sci 2016;24(5):518–523. DOI: 10.1590/1678-775720160170
  11. Ray P, Singh A, Dash JK, et al. Fragile X syndrome: a rare case report with unusual oral features. Contemp Clin Dent 2017;8(4):650–652. DOI: 10.4103/ccd.ccd_550_17
  12. Rajaratnam A, Shergill J, Salcedo-Arellano M, et al. Fragile X syndrome and fragile X-associated disorders. F1000Res 2017;6:2112. DOI: 10.12688/f1000research.11885.1
  13. Lozano R, Rosero CA, Hagerman RJ: Fragile X spectrum disorders. Intractable Rare Dis Res 2014;3(4):134–146. DOI: 10.5582/irdr.2014.01022
  14. Hagerman R, Hagerman P. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol 2013;12(8):786–798. DOI: 10.1016/S1474-4422(13)70125-X
  15. Lucá R, Averna M, Zalfa F, et al. The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med 2013;5(10):1523–1536. DOI: 10.1002/emmm.201302847
  16. Gurney ME, Cogram P, Deacon RM, et al. Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D). Sci Rep 2017;7(1):14653. DOI: 10.1038/s41598-017-15028-x
  17. Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med 2005;7(8):584–587. DOI: 10.1097/01.gim.0000182468.22666.dd
  18. Saldarriaga W, Tassone F, González-Teshima LY, et al. Fragile X syndrome. Colomb Med (Cali) 2014;45(4):190–198.
  19. Salti L, Rasse M, Al-Ouf K. Maxillofacial radiographic study of gardner's syndrome presenting with odontogenic myxoma: a rare case report. Stomatologija 2018;20(2):59–64.
  20. Kaufmann WE, Kidd SA, Andrews HF, et al. Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment. Pediatrics 2017;139(Supplement 3):S194–206. DOI: 10.1542/peds.2016-1159F
  21. Castagnola S, Bardoni B, Maurin T. The search for an effective therapy to treat fragile X syndrome: dream or reality? Front Synap Neurosc 2017;9:15. DOI: 10.3389/fnsyn.2017.00015
  22. Pittenger C, Bloch MH. Pharmacological treatment of obsessive-compulsive disorder. Psychiatr Clin North Am 2014;37(3):375–391. DOI: 10.1016/j.psc.2014.05.006
  23. Boffano P, Gallesio C, Barreca A, et al. Surgical treatment of odontogenic myxoma. J Craniofac Surg 2011;22(3):982–987. DOI: 10.1097/SCS.0b013e3182101400
  24. Augustine D, Sekar B, Saravannan S, et al. Myxoma of mandible –a case report with literature review. Int J Clin Den Sci 2014;5(1):17–19.
  25. Singh P, Nambiar KS, Rao RS, et al. A pediatric odontogenic myxoma of the maxilla: a case report and review. J Adv Clin Res Insights 2018;5(3):88–91. DOI: 10.15713/ins.jcri.219
  26. Augustine D, Rao RS, Kumar V, et al. Odontogenic myxoma with displaced third molar to coronoid process: role of differential stains to assess biologic behavior. World J Dent 2020;11(5):431–435. DOI: 10.5005/jp-journals-10015-1739
  27. Li TJ, Sun LS, Luo HY. Odontogenic myxoma: a clinicopathologic study of 25 cases. Arch Pathol Lab Med 2006;130(12):1799–1806. DOI: 10.5858/2006-130-1799-OMACSO
  28. Sato H, Kurihara Y, Shiogama S, et al. Long-term follow-up after conservative surgical treatment of odontogenic myxoma: a case report and literature review. Case Rep Dent 2019;2019:1634842. DOI: 10.1155/2019/1634842
  29. Chrcanovic BR, Gomez RS. Odontogenic myxoma: an updated analysis of 1,692 cases reported in the literature. Oral Dis 2019;25(3):676–683. DOI: 10.1111/odi.12875
  30. Saalim M, Sansare K, Karjodkar FR, et al. Recurrence rate of odontogenic myxoma after different treatments: a systematic review. Br J Oral Maxillofac Surg 2019;57(10):985–991. DOI: 10.1016/j.bjoms.2019.09.005
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.